resources / Ketamine Therapy
- Community Minds Team
- May 14, 2026
Esketamina is an FDA-approved nasal spray for treatment-resistant depression. Learn what esketamina is, how it works, conditions it treats, and what to expect.
Depression affects millions of people, and while many find relief with traditional medications, others continue to struggle despite trying multiple options. For those patients, new treatments are bringing hope. One of the most promising is esketamina, an FDA-approved nasal spray marketed under the brand name Spravato.
Patients often ask: what is esketamina, how does it work, and who can it help? The answer is that esketamina offers rapid relief for people with treatment-resistant depression or major depressive disorder with suicidal thoughts. It is administered in certified clinics under medical supervision, making it both safe and effective.
This article explains what esketamina is, how it works in the brain, the conditions it treats, its benefits, and what patients can expect when seeking care at Community Minds..
What Is Esketamina?
Esketamina is a nasal spray treatment derived from ketamine, developed specifically for psychiatric use.
A Derivative of Ketamine
While related to ketamine, esketamina was created to target depression in a more standardized way. It is administered intranasally and is less invasive than intravenous ketamine infusions.
FDA Approval in 2019
In 2019, the FDA approved esketamina under the brand name Spravato for treatment-resistant depression and for patients with major depressive disorder who experience suicidal thoughts. This approval signaled a major advancement in mental health care.
Administered Only in Certified Clinics
Esketamina cannot be taken at home. It must be administered in a certified clinic, where patients self-administer the nasal spray under the supervision of medical professionals.
How Esketamina Works
The science behind esketamina therapy explains why it can be effective, particularly compared to traditional antidepressants.
Acting on NMDA Receptors
Esketamina works by blocking NMDA receptors, which regulate glutamate signaling in the brain. Glutamate plays a key role in mood, cognition, and memory.
Promoting Neuroplasticity
By modulating glutamate, esketamina enhances neuroplasticity—the brain’s ability to create new pathways and connections. This flexibility can help patients break free from negative thought patterns.
Rapid Symptom Relief
Unlike oral antidepressants that may take weeks to show improvement, esketamina often produces noticeable changes within hours to days, offering fast relief for patients in crisis.
Conditions Treated with Esketamina
The primary use of esketamina is treating severe forms of depression, but research continues to expand its potential.
Treatment-Resistant Depression (TRD)
Esketamina is FDA-approved for patients who have not responded to at least two other antidepressant medications. For many, it has been the first treatment to provide meaningful relief.
Major Depressive Disorder with Suicidal Ideation
For patients experiencing suicidal thoughts, esketamina provides rapid stabilization. This makes it a critical option in urgent cases where time is of the essence.
Expanding Research
Clinical trials are exploring esketamina for additional conditions such as PTSD, anxiety disorders, and bipolar disorder. While these uses are not yet FDA-approved, early findings are promising.
- FDA-approved: TRD and MDD with acute suicidal ideation/behavior.
- Under study: PTSD, anxiety disorders, bipolar depression (off-label/not FDA-approved).
Benefits of Esketamina Therapy
Patients often want to know why esketamina might be a better option than traditional antidepressants or other therapies.
FDA-Approved Treatment
Because esketamina is FDA-approved, patients can feel confident in its safety and efficacy. It also means that many insurance providers cover the treatment, making it more accessible.
Rapid Relief
For individuals in crisis, one of the strongest benefits is the speed of improvement. Many patients report noticeable relief within the first few sessions.
Reduction in Suicidal Thoughts
Esketamina’s ability to reduce suicidal ideation within 24 hours provides a critical lifeline for those in urgent need.
Safe and Controlled Setting
Because treatment is only available in certified clinics, patients receive care in a safe, structured environment with continuous medical oversight.
- Rapid onset of action (hours–days).
- Insurance coverage often available.
- Monitored dosing in a certified clinic.
- Can complement ongoing psychotherapy.
Side Effects and Considerations
Like any treatment, esketamina has potential side effects. Most are mild, temporary, and carefully managed by providers.
Common Side Effects
- Dizziness
- Nausea
- Dissociation
- Fatigue or headache
Observation Period
After each session, patients remain in the clinic for at least two hours so providers can monitor their response and ensure safety before discharge.
Not a Cure-All
Esketamina is not a cure for depression. It works best when combined with psychotherapy, integration sessions, and other ongoing support.
Not Suitable for Everyone
Patients with uncontrolled cardiovascular conditions, a history of psychosis, or certain other health issues may not be eligible. A thorough evaluation determines suitability.
What to Expect During Treatment
At Community Minds, patients receiving esketamina therapy follow a structured process that emphasizes both safety and comfort.
Pre-Treatment Evaluation
Patients begin with a medical evaluation to confirm eligibility and create a personalized treatment plan.
Administration in Clinic
During the session, the patient self-administers the esketamina nasal spray while being closely supervised by staff.
Observation and Monitoring
After dosing, patients stay in the clinic for two hours while providers monitor vital signs and any side effects.
Multi-Week Treatment Plan
Esketamina therapy usually starts with two sessions per week for four weeks, followed by a tapering schedule or maintenance treatments depending on patient needs.
- Week 1–4: Typically 2 sessions/week.
- Weeks 5+: Taper to weekly or biweekly as indicated.
- Ongoing: Maintenance sessions individualized to response.
Community Minds and Esketamina Treatment
For patients who have not found relief with traditional antidepressants, esketamina represents a breakthrough. With FDA approval, rapid results, and a strong safety record, it has become one of the most important advancements in modern mental health care.
At Community Minds, we provide safe, structured esketamina treatment with individualized care and continuous monitoring. Our team helps patients find stability, reduce symptoms, and improve quality of life.
FAQs: Esketamina
What is esketamina?
How does esketamina work?
Who qualifies for esketamina therapy?
What are the side effects of esketamina?
Is esketamina covered by insurance?
Disclaimer: The information provided here is for informational purposes only and should not be considered professional advice. Always seek guidance from a qualified professional before making decisions based on this content.
Take the First Step Today
Find out which plans are covered. Unsure? Give us a call.
- Community Minds Team
- May 14, 2026
Free resources, created just for you!
Access articles, blogs, meditations and more. Have suggestions for free resources? Contact us.
